Priyadeep Bhutani

893 total citations · 1 hit paper
18 papers, 701 citations indexed

About

Priyadeep Bhutani is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Priyadeep Bhutani has authored 18 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Pharmacology. Recurrent topics in Priyadeep Bhutani's work include Pharmacogenetics and Drug Metabolism (5 papers), HIV Research and Treatment (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Priyadeep Bhutani is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), HIV Research and Treatment (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Priyadeep Bhutani collaborates with scholars based in India, United States and Germany. Priyadeep Bhutani's co-authors include Atish T. Paul, K Prabhakar, Raj Kumar, Gaurav Joshi, Hemant Bhutani, Murali Subramanian, Sandhya Mandlekar, Mark Krystal, Anoop Kumar and John F. Kadow and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Drug Metabolism and Disposition.

In The Last Decade

Priyadeep Bhutani

18 papers receiving 689 citations

Hit Papers

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective 2021 2026 2022 2024 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priyadeep Bhutani India 8 445 188 73 68 51 18 701
Hong X. Ding China 12 400 0.9× 203 1.1× 114 1.6× 84 1.2× 35 0.7× 12 618
Sarah J. Fink United States 13 347 0.8× 179 1.0× 89 1.2× 76 1.1× 30 0.6× 19 547
André Alker Switzerland 14 364 0.8× 243 1.3× 74 1.0× 38 0.6× 28 0.5× 31 695
Murugaiah A. M. Subbaiah India 14 808 1.8× 184 1.0× 74 1.0× 117 1.7× 25 0.5× 28 1.0k
Zhao‐Kui Wan United States 19 715 1.6× 397 2.1× 43 0.6× 71 1.0× 45 0.9× 31 1.0k
Andrew C. Flick United States 21 829 1.9× 340 1.8× 144 2.0× 148 2.2× 70 1.4× 39 1.1k
Carl Berthelette Canada 19 428 1.0× 200 1.1× 60 0.8× 64 0.9× 52 1.0× 25 705
Robert Webster Canada 11 449 1.0× 210 1.1× 39 0.5× 149 2.2× 53 1.0× 15 713
Michael E. Pierce United States 14 764 1.7× 334 1.8× 75 1.0× 70 1.0× 23 0.5× 29 1.1k
Antonia Di Mola Italy 20 814 1.8× 249 1.3× 31 0.4× 45 0.7× 32 0.6× 69 1.1k

Countries citing papers authored by Priyadeep Bhutani

Since Specialization
Citations

This map shows the geographic impact of Priyadeep Bhutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priyadeep Bhutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priyadeep Bhutani more than expected).

Fields of papers citing papers by Priyadeep Bhutani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priyadeep Bhutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priyadeep Bhutani. The network helps show where Priyadeep Bhutani may publish in the future.

Co-authorship network of co-authors of Priyadeep Bhutani

This figure shows the co-authorship network connecting the top 25 collaborators of Priyadeep Bhutani. A scholar is included among the top collaborators of Priyadeep Bhutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priyadeep Bhutani. Priyadeep Bhutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Arora, Sahil, Manvendra Kumar, Gaurav Joshi, et al.. (2023). Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities. Journal of Medicinal Chemistry. 66(5). 3135–3172. 24 indexed citations
2.
Subbaiah, Murugaiah A. M., Sarmistha Halder Sinha, Sandhya Mandlekar, et al.. (2022). Improving Drug Delivery While Tailoring Prodrug Activation to Modulate Cmax and Cmin by Optimization of (Carbonyl)oxyalkyl Linker-Based Prodrugs of Atazanavir. Journal of Medicinal Chemistry. 65(16). 11150–11176. 2 indexed citations
3.
Bhutani, Priyadeep, Gaurav Joshi, K Prabhakar, et al.. (2021). U.S. FDA Approved Drugs from 2015–June 2020: A Perspective. Journal of Medicinal Chemistry. 64(5). 2339–2381. 566 indexed citations breakdown →
4.
Subbaiah, Murugaiah A. M., Sarmistha Halder Sinha, Sandhya Mandlekar, et al.. (2020). (Carbonyl)oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentration. European Journal of Medicinal Chemistry. 207. 112749–112749. 5 indexed citations
6.
Bhutani, Priyadeep, K Prabhakar, & Atish T. Paul. (2020). Impact of quercetin on pharmacokinetics of quetiapine: insights from in-vivo studies in wistar rats. Xenobiotica. 50(12). 1483–1489. 5 indexed citations
8.
Subbaiah, Murugaiah A. M., Sandhya Mandlekar, Sridhar Desikan, et al.. (2019). Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir. Journal of Medicinal Chemistry. 62(7). 3553–3574. 24 indexed citations
9.
Patil, Amol, Shyam H. Kamble, Benjamin M. Johnson, et al.. (2019). Identification of novel glutathione conjugates of terbinafine in liver microsomes and hepatocytes across species. Xenobiotica. 49(12). 1403–1413. 1 indexed citations
10.
Subbaiah, Murugaiah A. M., Nicholas A. Meanwell, John F. Kadow, et al.. (2018). Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir. Journal of Medicinal Chemistry. 61(9). 4176–4188. 13 indexed citations
12.
Bhutani, Priyadeep, et al.. (2018). Offline Derivatization LC–MS/MS Method for Simultaneous Estimation of Vanillin and Vanillic Acid in Guinea Pig Plasma. Bioanalysis. 10(3). 131–142. 8 indexed citations
13.
Bhutani, Priyadeep, et al.. (2016). Absolute Quantification of Imipramine and its Metabolites In Vivo Utilizing Calibrators from Radiolabeled In Vitro Incubations. Bioanalysis. 8(4). 297–309. 2 indexed citations
14.
Zvyaga, Tatyana, et al.. (2016). Comprehensive evaluation of liver microsomal cytochrome P450 3A (CYP3A) inhibition: comparison of cynomolgus monkey and human. Xenobiotica. 47(6). 470–478. 2 indexed citations
15.
Holenarsipur, Vinay K., Sobha Sivaprasad, Priyadeep Bhutani, et al.. (2015). Absorption and cleavage of enalapril, a carboxyl ester prodrug, in the rat intestine: in vitro, in situ intestinal perfusion and portal vein cannulation models. Biopharmaceutics & Drug Disposition. 36(6). 385–397. 15 indexed citations
16.
Subramanian, Murali, T. Thanga Mariappan, Punit H. Marathe, et al.. (2014). Role of hepatic blood flow and metabolism in the pharmacokinetics of ten drugs in lean, aged and obese rats. Xenobiotica. 44(12). 1108–1116. 12 indexed citations
17.
Bhutani, Priyadeep, Kaushik Ghosh, Manjunath Ramarao, et al.. (2013). Expression and Characterization of Cynomolgus Monkey Cytochrome CYP3A4 in a Novel Human Embryonic Kidney Cell–Based Mammalian System. Drug Metabolism and Disposition. 42(3). 369–376. 5 indexed citations
18.
Aggarwal, Anju, et al.. (1987). Tropical splenomegaly syndrome and the role of chloroquine prophylaxis.. PubMed. 85(10). 298–300. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026